Regeneron Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
15.1812.669.778.97
Price/Sales ratio
4.133.853.583.37
Earnings per Share (EPS)
$37.84$45.39$58.78$64.05

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
133.6798.3447.6536.3517.5419.3714.798.2617.8123.7020.2117.54
Price/Sales ratio
16.5015.248.777.426.385.216.114.156.347.147.206.38
Price/Book Value ratio
18.3017.119.597.094.893.694.713.553.403.603.863.86
Price/Cash Flow ratio
61.8347.0028.7133.3319.5316.8719.859.4215.4020.3917.4817.48
Price/Free Cash Flow ratio
110.9395.8143.8142.1223.6620.4925.9410.2217.4625.5525.8023.66
Price/Earnings Growth ratio
-6.491.171.231.140.19-2.160.210.06-0.37-2.77-0.45-2.16
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
92.72%90.43%93.83%93.23%93.53%90.05%86.82%84.83%87.18%86.15%87.18%90.05%
Operating Profit Margin
29.73%30.50%27.37%35.41%37.76%28.10%42.09%55.66%38.92%30.85%39.17%37.76%
Pretax Profit Margin
27.51%29.85%27.36%35.39%38.05%30.89%44.84%58.02%39.91%32.01%39.91%38.05%
Net Profit Margin
12.34%15.49%18.42%20.40%36.42%26.90%41.34%50.24%35.63%30.14%35.63%26.90%
Effective Tax Rate
55.13%48.08%32.65%42.33%4.27%12.89%7.79%13.40%10.71%5.85%10.71%4.27%
Return on Assets
8.98%11.33%12.84%13.67%20.83%14.29%20.46%31.74%14.85%11.95%14.85%14.29%
Return On Equity
13.69%17.40%20.12%19.50%27.91%19.07%31.86%43.02%19.14%15.22%20.48%19.07%
Return on Capital Employed
25.78%25.82%22.20%26.67%24.41%16.97%24.91%40.69%18.68%13.64%18.29%16.97%
Liquidity Ratios
Current Ratio
3.313.592.563.814.463.664.54N/AN/AN/A5.054.46
Quick Ratio
3.834.133.585.035.035.103.865.385.104.934.165.10
Cash ratio
1.041.060.540.841.080.900.780.830.800.790.980.98
Days of Sales Outstanding
126.39130.55121.02122.71122.0097.47176.75137.09159.77157.69159.77122.00
Days of Inventory outstanding
229.41221.74486.37667.50967.95660.51624.66292.19561.83518.71439.78660.51
Operating Cycle
355.80352.29607.40790.221.08K757.99801.41429.28721.61676.41479.18757.99
Days of Payables Outstanding
177.15131.01164.39163.81183.46195.09154.9784.45137.82121.93137.82195.09
Cash Conversion Cycle
178.65221.27443.00626.41906.49562.89646.43344.83583.79554.47130.39562.89
Debt Ratios
Debt Ratio
0.03N/AN/AN/AN/AN/A0.110.100.060.050.22N/A
Debt Equity Ratio
0.05N/AN/AN/AN/AN/A0.170.140.080.070.28N/A
Long-term Debt to Capitalization
0.05N/AN/AN/AN/AN/A0.150.090.080.070.10N/A
Total Debt to Capitalization
0.05N/AN/AN/AN/AN/A0.150.120.080.070.13N/A
Interest Coverage Ratio
22.4387.90184.9582.7889.8773.1762.85N/AN/AN/A80.2873.17
Cash Flow to Debt Ratio
5.12N/AN/AN/AN/AN/A1.322.622.532.311.46N/A
Company Equity Multiplier
1.521.531.561.421.331.331.551.351.281.271.281.33
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.260.320.300.220.320.300.300.440.410.350.410.32
Free Cash Flow / Operating Cash Flow Ratio
0.550.490.650.790.820.820.760.920.880.790.670.82
Cash Flow Coverage Ratio
5.12N/AN/AN/AN/AN/A1.322.622.532.311.46N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A9.83N/AN/A6.96N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A